Background {#sec1_1}
==========

Hepatic portal venous gas (HPVG) was first described by Wolfe and Evans \[[@B1]\] in 1955 in infants with fatal necrotizing enterocolitis and was found to have a 75% mortality rate \[[@B2]\]. The development of imaging techniques enables earlier detection of even minute quantities of air in the portal system, resulting in a significant reduction in mortality \[[@B3]\]. HPVG is induced by various abdominal conditions such as bowel ischemia, inflammatory bowel diseases, bowel obstruction, diverticulitis, appendicitis, intra-abdominal abscess and gastric dilatation \[[@B3], [@B4], [@B5], [@B6]\]. Because HPVG is accompanied by bowel ischemia, intestinal infection and hypovolemia, various modes of critical management are needed to ensure recovery in parallel with treatment of the underlying conditions. Recently, many researchers have comprehensively described the pathophysiology of HPVG. However, there is scant literature on HPVG induced by postoperative complications after abdominal surgery. We report 4 patients with HPVG occurring after abdominal surgery. We describe the clinical course of their postoperative complications resulting in HPVG and unique therapeutic options for this severe condition.

Case Reports {#sec1_2}
============

Case 1 {#sec2_1}
------

A 70-year-old woman underwent pylorus-preserving pancreatoduodenectomy for bile duct carcinoma. Enteral nutrition through the intraoperatively placed jejunostomy tube was started on postoperative day (POD) 1.

On POD 4, she complained about abdominal discomfort. It first improved after defecation, but abdominal distension was observed subsequently and gradually aggravated. On the morning of POD 5, she suddenly developed loss of consciousness accompanied by hyperventilation and general cyanosis, which we considered to be a hypovolemic shock of unknown origin. Fluid resuscitation with the administration of catecholamine did not improve her general condition.

During the afternoon of POD 5, she developed oliguria. On physical examination, we observed abdominal distension, tenderness and mild muscle defense. Computed tomography (CT) showed diffuse intraluminal gas in the gastrointestinal tract from the lower esophagus to the ileocecal portion and portal venous gas infiltrating the bilateral lobes of the liver (fig. [1a, b](#F1){ref-type="fig"}). An emergent laparotomy was performed, and piebald ischemia of the intestinal wall was observed from the stomach to the ileocecal portion with a marked stench. A tentative diagnosis of nonocclusive mesenteric ischemia was made, and extensive resection of the small intestine was performed. After surgery, we continued fluid resuscitation with administration of catecholamine, but her general condition did not improve. She died of multiple organ failure on the evening of POD 5.

Case 2 {#sec2_2}
------

An 82-year-old woman with a history of hypertension and type II diabetes mellitus underwent total gastrectomy with Roux-en-Y reconstruction for advanced gastric carcinoma. Oral intake was started on POD 2, but she developed aspiration pneumonia that was treated with an antibiotic. Enteral nutrition through the jejunostomy tube placed during surgery was started from POD 3.

On POD 6, she restarted oral intake because aspiration pneumonia was healed. But on POD 8, she developed severe diarrhea. Although she was treated conservatively with sufficient intravenous infusion, her general condition was abruptly exacerbated by the appearance of multiple organ dysfunction. On POD 15, CT revealed diffuse intraluminal gas in the small intestine and portal venous gas infiltrating the bilateral lobes of the liver (fig. [1c, d](#F1){ref-type="fig"}). Finally, she died of multiple organ failure on POD 18.

Case 3 {#sec2_3}
------

An 81-year-old man with no previous history was admitted to our institution for treatment of advanced gastric cancer with pyloric obstruction. A nasogastric tube was inserted to relieve nausea and vomiting, yielding approximately 1,000 ml of tan-colored gastric juice per day. He underwent further evaluation of TNM staging and preoperative risk factors, and the dehydration induced by the loss of gastric juice was resolved. On the 11th day after admission, he developed septic shock following urinary tract infection, which was treated by fluid resuscitation and administration of a broad-spectrum antibiotic. He had recovered by the 14th day with this conservative therapy. Radiologic examinations revealed no distant metastasis or peritoneal dissemination, and on the 18th day, he underwent laparotomy. Although the main lesion showed infiltrative growth to the right mesocolon, no unresectable areas were identified by abdominal exploration. A total gastrectomy with regional lymph node dissection and Roux-en-Y reconstruction was performed. The resected specimen showed marked infiltration to the surrounding peritoneal tissues, forming a scirrhous configuration. Because the patient had fasted for almost 1 month preoperatively, enteral feeding with sufficient glutamine was started through the jejunostomy tube on POD 4.

On POD5, he developed septic phlebitis associated with the jugular venous catheter that was promptly treated by removal of the catheter. From POD 10, massive watery diarrhea had been observed. On POD 12, his abdomen suddenly showed marked distension with severe cramping, followed by both explosive vomiting of blood-tinged contents and diarrhea. Blood investigations revealed leukocytosis 16.5 ×10^9^/l, C-reactive protein 100.1 mg/l, urea 11.7 mmol/l, creatinine 81.3 μmol/l and a base excess of −4.0 mEq/l. CT revealed marked dilation of the small intestine, which was filled with fluid, and HPVG occupying the left lobe of the liver (fig. [2a, b](#F2){ref-type="fig"}). Nonocclusive mesenteric ischemia induced by severe enteritis was diagnosed. Fluid resuscitation and continuous suction of intestinal juice through the jejunostomy tube resulted in prompt recovery. Disappearance of the HPVG was confirmed on POD 15 (fig. [2c](#F2){ref-type="fig"}). He was discharged in good condition on POD 43.

Case 4 {#sec2_4}
------

A 70-year-old man underwent abdominoperineal resection for locally advanced rectal carcinoma. The primary lesion showed serosal layer invasion with infiltration to the sacrum, and the blood loss during surgery was more than 3,000 ml. On POD 2, localized necrosis seemingly due to impaired vascular perfusion of the colostomy was observed that was treated by debridement.

On POD 14, sudden steatorrhea and melena appeared. He was conscious but cyanotic and sweating profusely over his entire body. A complete blood count revealed marked normochromic anemia with a hemoglobin of 7.1 g/dl. CT showed dilation of the gastric wall with fluid collection. In addition, HPVG was recognized from the biliary tree in the left lobe of the liver to the cephalad half of the superior mesenteric vein (fig. [2d](#F2){ref-type="fig"}). After fluid resuscitation and sufficient volume of blood transfusion, he underwent endoscopic hemostasis by hemoclip for a hemorrhagic gastric ulcer. His general condition promptly improved. We confirmed the disappearance of HPVG by CT on POD 24 (fig. [2e](#F2){ref-type="fig"}). He was discharged in good condition on POD 84.

Discussion {#sec1_3}
==========

A prominent feature of this case series is that HPVG was detected postoperatively during the management of abdominal complications (table [1](#T1){ref-type="table"}). In cases 1 and 2, the patients experienced abrupt onset and severe sepsis when HPVG was recognized. Neither fluid resuscitation nor surgical management improved their life-threatening status. Although we cannot sufficiently explain the pathophysiology behind these two fatal cases, we infer that HPVG was induced by hypovolemia and infection after surgery. Especially in case 2, severe sepsis with HPVG followed the onset of aspiration pneumonia and enteritis. When the postoperative infection was recognized, we should have considered treatment with sufficient fluids to avoid severe hypovolemia. In case 2, there was no sentinel sign before the onset of HPVG. Given that one important pathogenesis of HPVG is increased intestinal pressure, we retrospectively presume that early initiation of enteral feeding was associated with the appearance of HPVG in these two cases. Although the ERAS (enhanced recovery after surgery) protocol widely prevails in the management of gastrointestinal surgery, and this protocol is generally considered to play an important role in early patient recovery postoperatively, a gradual increase in enteral feeding with sufficient parenteral fluid administration is needed for critically ill patients after surgery.

In cases 3 and 4, conservative therapy resulted in favorable postoperative courses. In case 4, postoperative hypovolemia was induced by bleeding from a gastric ulcer, and no infection was observed. We believe that in case 4, neither failure of the intestinal barrier nor increased intestinal pressure was associated with the appearance of HPVG, thus leading to the early improvement in this patient.

In case 3, HPVG appeared after severe enteritis, suggesting intestinal failure. We performed fluid resuscitation with continuous drainage of the intestine through the intraoperatively placed jejunostomy tube, which yielded abundant intestinal fluids with malodorous gas. We suggest the possibility that intestinal decompression is an effective therapeutic option for severe complications accompanied by HPVG.

Although the presence of gas in the portal venous system was generally considered to be a serious intra-abdominal event, many benign cases have been put forward with the development of imaging modalities. Our search for reported cases of HPVG during the most recent 5 years (table [2](#T2){ref-type="table"}) \[[@B3], [@B4], [@B5], [@B6], [@B7], [@B8], [@B9], [@B10], [@B11], [@B12], [@B13], [@B14], [@B15], [@B16], [@B17], [@B18], [@B19], [@B20], [@B21], [@B22], [@B23], [@B24], [@B25], [@B26], [@B27], [@B28], [@B29], [@B30], [@B31], [@B32]\] revealed that 20 of the 31 patients were treated by a nonsurgical approach, and 22 (71%) of the 31 patients recovered, suggesting that HPVG is not always a fatal sign in those patients. In addition, invasive therapy, including chemotherapy, endoscopic retrograde cholangiopancreatography, and CT-guided aspiration biopsy, was performed in 14 (45.2%) of the 31 patients before onset of HPVG. Abdominal surgery is also an invasive treatment, especially in elderly patients. Care should be taken to recognize postoperative HPVG on CT imaging. Early detection and initiation of conservative therapy including fluid resuscitation and intestinal decompression are needed to obtain a favorable patient outcome.
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![Abdominal CT findings of cases 1 and 2. HPVG infiltrates throughout the intrahepatic portal branches (arrows) \[case 1 (**a**); case 2 (**c**)\] accompanied by diffuse intraluminal gas along the small intestinal wall (arrowheads) \[case 1 (**b**); case 2 (**d**)\].](crg-0010-0099-g01){#F1}

![Abdominal CT findings of cases 3 and 4 HPVG (arrows) \[case 3 (**a**); case 4 (**d**)\] with intraluminal gas of the small intestine (arrowheads) \[case 3 (**b**)\] are observed. Disappearance of HPVG is confirmed by CT after conservative treatment \[case 3 (**c**); case 4 (**e**)\].](crg-0010-0099-g02){#F2}

###### 

Summary of the clinical features of our four cases

  Case No.   Age/sex   Disease               Operation                                  Onset time of HPVG   Symptom                 Treatment      Outcome
  ---------- --------- --------------------- ------------------------------------------ -------------------- ----------------------- -------------- ---------
  1          70/F      bile duct carcinoma   pylorus-preserving pancreatoduodenectomy   POD 5                loss of consciousness   operation      death
  2          82/F      gastric carcinoma     total gastrectomy                          POD 15               diarrhea                conservative   death
  3          81/M      gastric carcinoma     total gastrectomy                          POD 12               diarrhea hematemesis    conservative   alive
  4          70/M      rectal carcinoma      abdominoperineal resection                 POD 14               melena                  conservative   alive

###### 

Summary of the clinical features of reported cases of HPVG during the most recent 5 years \[[@B3], [@B4], [@B5], [@B6], [@B7], [@B8], [@B9], [@B10], [@B11], [@B12], [@B13], [@B14], [@B15], [@B16], [@B17], [@B18], [@B19], [@B20], [@B21], [@B22], [@B23], [@B24], [@B25], [@B26], [@B27], [@B28], [@B29], [@B30], [@B31], [@B32]\]

  ------------------------------------ ---- -------------------------------------- ----
  All cases                            31   Presence of sepsis                     5
  Sex                                       Presence of shock                      6
   Male                                15   Treatment                              
   Female                              14   Conservative                           17
   Not mentioned                       2    Operation                              10
  Age                                       Appendectomy and Hartmann              1
   \<65                                16   Gastrojejunostomy                      1
   ≥65                                 15   Hartmann                               1
  Past history                              Ileocecal resection                    2
   Diabetes mellitus                   9    Jejunum resection                      2
   Renal disease                       5    Fibrotic adhesion resection            1
   Hemodialysis                        3    Right hemicolectomy                    2
  Symptom                                   Percutaneous drainage                  3
   Abdominal pain                      19   Not mentioned                          1
   Abdominal discomfort                1    Outcome                                
   Abdominal distension                5    Alive                                  22
   Vomiting                            8    Death                                  7
   Nausea                              2    Not mentioned                          2
   Diarrhea                            2    Survival time in fetal cases (n = 7)   
   Fever                               5    ≤1 day                                 2
   Asymptomatic                        3    1 day\<, ≤3 days                       3
  Diagnosis (investigation)                 3 days\<, ≤7 days                      1
   CT                                  29   ≤7 days                                1
   Abdominal radiography               2                                           
   Ultrasonography                     3                                           
   Autopsy                             1                                           
  Cases undergone some interventions                                               
   before development of HPVG          14                                          
   Right hemicolectom                  1                                           
   PEG                                 1                                           
   CT-guided liver biopsy              1                                           
   Gastrointestinal endoscopy          1                                           
   Endoscopic balloon dilatation       1                                           
   ERCP for bile duct stones           1                                           
   Angiogram for AMI                   1                                           
   IABP                                1                                           
   Dialysis                            1                                           
   Allo-PBSCT                          1                                           
   Gefitinib, sorafenib, bevacizumab   3                                           
   Budesonide for Crohn\'s disease     1                                           
  ------------------------------------ ---- -------------------------------------- ----
